Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP638358.RAUfTMnJizaBq0ZiBAQW-f9yhEM69x-7p9N-OEcdEj7UE130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638358.RAUfTMnJizaBq0ZiBAQW-f9yhEM69x-7p9N-OEcdEj7UE130_provenance.
• NP257708.RAgCY0ybhIofArbkfKtigglFuVY7jWDWMz87FJ3xwHl3g130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP257708.RAgCY0ybhIofArbkfKtigglFuVY7jWDWMz87FJ3xwHl3g130_provenance.
• NP349266.RAe78mY9TwZfOb_Qguo4SKW0EG_nKhqaxpmTExPOv0sGA130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349266.RAe78mY9TwZfOb_Qguo4SKW0EG_nKhqaxpmTExPOv0sGA130_provenance.
• NP622926.RAbQD12jTsfoiSy8kz1oxT9oTwRPKqXOxbQoH7rK3fYpo130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622926.RAbQD12jTsfoiSy8kz1oxT9oTwRPKqXOxbQoH7rK3fYpo130_provenance.
• NP310294.RA17tJX0PKmL0u37zniBDJVNghOvWRvMsCdAnaSxGCS8E130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310294.RA17tJX0PKmL0u37zniBDJVNghOvWRvMsCdAnaSxGCS8E130_provenance.
• NP650282.RA09wC7IEn_yL16gE4loj5GiDAy0RLOKkEXi17lMJgiLM130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650282.RA09wC7IEn_yL16gE4loj5GiDAy0RLOKkEXi17lMJgiLM130_provenance.
• NP690713.RAwFhkiPCWtRPoEoi21yrxRp-_sV6Max8dyeIRLBNMFF0130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690713.RAwFhkiPCWtRPoEoi21yrxRp-_sV6Max8dyeIRLBNMFF0130_provenance.
• NP919974.RA79TJwhb2mW76qCoCyveSmEq5mFiL0EF9PPeggIruXRo130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919974.RA79TJwhb2mW76qCoCyveSmEq5mFiL0EF9PPeggIruXRo130_provenance.
• NP502762.RAf0wxaXNgucPscJj6zgamWAEGa2AR8fAADCCHSc-sH6Q130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502762.RAf0wxaXNgucPscJj6zgamWAEGa2AR8fAADCCHSc-sH6Q130_provenance.
• NP602507.RAZh6sSJxKQ2qmva5Pl-jKkwlJa7GgtEm362SG69bjuwY130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602507.RAZh6sSJxKQ2qmva5Pl-jKkwlJa7GgtEm362SG69bjuwY130_provenance.
• NP939404.RAZh7FkuI9NE0ucKGwIhPG0auUlfUXLl9tLcykWQaf9Ds130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939404.RAZh7FkuI9NE0ucKGwIhPG0auUlfUXLl9tLcykWQaf9Ds130_provenance.
• NP698762.RAJH5xJmRXQe8uHLjPSFVQshJoi0RgbVJMrQaFgiXE1r0130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698762.RAJH5xJmRXQe8uHLjPSFVQshJoi0RgbVJMrQaFgiXE1r0130_provenance.
• NP969741.RARv7t81ifW59EBJdBrx3T94F20wmGUYlp-ofCAs21tvA130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969741.RARv7t81ifW59EBJdBrx3T94F20wmGUYlp-ofCAs21tvA130_provenance.
• NP969745.RATIgtWq6I-Incks8ZlJHVA0qUkK4bI0XlaXjHln5kKaM130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969745.RATIgtWq6I-Incks8ZlJHVA0qUkK4bI0XlaXjHln5kKaM130_provenance.
• NP969746.RAeKTircLnV1FMb7dGlcItkQgA7IFPjoG-tLWTDKRTDEA130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969746.RAeKTircLnV1FMb7dGlcItkQgA7IFPjoG-tLWTDKRTDEA130_provenance.
• NP501683.RAAjrQoiKaeiNnEOpkWB01j_Okc6oyLOvdhtiYD3RsXAo130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501683.RAAjrQoiKaeiNnEOpkWB01j_Okc6oyLOvdhtiYD3RsXAo130_provenance.
• NP227026.RACLhQu9RINkGQkuLsJagSFU0B_MdRcRKafPFk8xrDEmg130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227026.RACLhQu9RINkGQkuLsJagSFU0B_MdRcRKafPFk8xrDEmg130_provenance.
• NP842090.RABCKTXGc04DQLsdJBi3UzoVyOMepqfwllnlkbVhH-ccE130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842090.RABCKTXGc04DQLsdJBi3UzoVyOMepqfwllnlkbVhH-ccE130_provenance.
• NP906941.RAl27xo6oSrqhFLiy8ofYxcQMNYdIAo_risKjRAPxOE70130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906941.RAl27xo6oSrqhFLiy8ofYxcQMNYdIAo_risKjRAPxOE70130_provenance.
• NP969738.RAvKqGt86IhU5N7HJ7gAOUkeDzy2Tr5ximuX7pc0E0qFQ130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969738.RAvKqGt86IhU5N7HJ7gAOUkeDzy2Tr5ximuX7pc0E0qFQ130_provenance.
• NP969743.RArWIObr0TwB-Lqf530qaWqQxs5MJ4qm9jEjjnqBMSvpQ130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969743.RArWIObr0TwB-Lqf530qaWqQxs5MJ4qm9jEjjnqBMSvpQ130_provenance.
• NP969748.RAmNoVeNzQA1NMYj7CxaQu4yiMR0UWyoauVJ9rCONdxVM130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969748.RAmNoVeNzQA1NMYj7CxaQu4yiMR0UWyoauVJ9rCONdxVM130_provenance.
• NP587860.RAMa_f5Bsz5QPrfR3J2MV01thABwEjsNdmH1WJ1qzNb1Y130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587860.RAMa_f5Bsz5QPrfR3J2MV01thABwEjsNdmH1WJ1qzNb1Y130_provenance.
• NP295321.RAEgF72z-REvJneo4PweSrJfNRGJhOPQiIQbekdU3jytw130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295321.RAEgF72z-REvJneo4PweSrJfNRGJhOPQiIQbekdU3jytw130_provenance.
• NP502396.RAPcuaPeqvbQg6VkJFhSSWem5TIPYTa2nCWAXhaexJ_Ww130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502396.RAPcuaPeqvbQg6VkJFhSSWem5TIPYTa2nCWAXhaexJ_Ww130_provenance.
• NP969740.RAJPXDUj2-6HKowyOQGqiR2UTiPkt4TP7GXpwbGbhEp4c130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969740.RAJPXDUj2-6HKowyOQGqiR2UTiPkt4TP7GXpwbGbhEp4c130_provenance.
• NP969744.RAKHIrDC04CsJa0blV6c1JXhz9gIViAABdvAmO0Uu2FZg130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969744.RAKHIrDC04CsJa0blV6c1JXhz9gIViAABdvAmO0Uu2FZg130_provenance.
• NP969747.RAF956zMBG49yVi9vCJgQbkdKzh6rZoKFchtDR05RDmIY130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969747.RAF956zMBG49yVi9vCJgQbkdKzh6rZoKFchtDR05RDmIY130_provenance.
• NP969749.RAE0w0Wbbm9LwHXSzkgJIe_4rrOsB-w3X8Y9GKauOAkk0130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969749.RAE0w0Wbbm9LwHXSzkgJIe_4rrOsB-w3X8Y9GKauOAkk0130_provenance.
• NP816298.RAwR-pPEOcp3AdVc6QNnUKqzsrvSGcUtvv-Q7ZWcE3MwU130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816298.RAwR-pPEOcp3AdVc6QNnUKqzsrvSGcUtvv-Q7ZWcE3MwU130_provenance.
• NP684749.RA4EQpK5hN8WV61YMkjUoi4W4629ZZoFQOUmjE4ol5Fds130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684749.RA4EQpK5hN8WV61YMkjUoi4W4629ZZoFQOUmjE4ol5Fds130_provenance.
• NP969739.RA5-PeIwfdRcaQtvdP1_RmsbaVo1H93hPIRrOzuRjYxec130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969739.RA5-PeIwfdRcaQtvdP1_RmsbaVo1H93hPIRrOzuRjYxec130_provenance.
• NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_provenance.